This work develops a non-peptide probe for detecting chymotrypsin in vitro, indicating improved stability and accuracy.
The work presents the development of a non-peptide fluorescent probe, NQ , for in vitro detection of chymotrypsin (Chy). Unlike traditional peptide-based probes that suffer from instability and enzymatic degradation, NQ incorporates hydrocinnamoyl chloride as a recognition group, offering enhanced stability under physiological conditions. Upon enzymatic cleavage by Chy, the probe releases a fluorogenic product (NQOH), generating a turn-on fluorescence signal. NQ exhibits a rapid initial response, with a distinguishable fluorescence signal generated within 10 min, and a low detection limit of 7.64 ng/mL. Although the enzymatic reaction reaches saturation over a period of 30-60 min, the rapid initial turn-on allows for rapid qualitative screening. A notable feature is the probe's large Stokes shift (177nm) combined with an efficient non-peptidic recognition group. This synergistic design significantly improves detection accuracy by minimizing background interference and resisting non-specific degradation in complex biological environments. The probe showed effective performance in HepG2 cell models, confirming its suitability for biological applications. This study underscores the value of non-peptide probe designs for fast and precise enzyme detection in complex biological environments.
No takes yet. Share an insight, caveat, or question.
AbhijnaKrishna et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: